LFST
Income statement / Annual
Last year (2023), LifeStance Health Group, Inc.'s total revenue was $1.06 B,
an increase of 22.82% from the previous year.
In 2023, LifeStance Health Group, Inc.'s net income was -$186.26 M.
See LifeStance Health Group, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$1.06 B
|
$859.54 M
|
$667.51 M
|
$377.22 M
|
$212.52 M
|
| Cost of Revenue |
$753.57 M |
$622.53 M |
$466.00 M |
$242.90 M |
$150.12 M |
| Gross Profit |
$302.10 M |
$237.02 M |
$201.51 M |
$134.32 M |
$62.40 M |
| Gross Profit Ratio |
0.29 |
0.28 |
0.3 |
0.36 |
0.29 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$410.79 M
|
$377.99 M
|
$433.73 M
|
$69.65 M
|
$41.06 M
|
| Selling & Marketing
Expenses |
$0.00
|
$8.63 M
|
$1.94 M
|
$2.61 M
|
$646,000.00
|
| Selling, General &
Administrative Expenses |
$410.79 M
|
$377.99 M
|
$433.73 M
|
$330.74 M
|
$41.06 M
|
| Other Expenses |
$80.44 M |
$69.20 M |
$54.14 M |
$0.00 |
$6.10 M |
| Operating Expenses |
$491.23 M |
$447.19 M |
$487.86 M |
$330.74 M |
$47.16 M |
| Cost And Expenses |
$1.24 B |
$1.07 B |
$953.86 M |
$361.78 M |
$197.28 M |
| Interest Income |
$0.00 |
$19.93 M |
$38.91 M |
$22.13 M |
$5.41 M |
| Interest Expense |
$21.22 M |
$19.93 M |
$38.91 M |
$22.13 M |
$5.41 M |
| Depreciation &
Amortization |
$80.44 M
|
$69.20 M
|
$54.14 M
|
$31.05 M
|
$6.10 M
|
| EBITDA |
-$104.93 M
|
-$136.41 M
|
-$229.62 M
|
$8.77 M
|
$21.34 M
|
| EBITDA Ratio |
-0.1 |
-0.16 |
-0.35 |
0.12 |
0.1 |
| Operating Income Ratio
|
-0.18
|
-0.24
|
-0.43
|
0.04
|
0.07
|
| Total Other
Income/Expenses Net |
-$17.45 M
|
-$22.56 M
|
-$46.75 M
|
-$59.85 M
|
-$7.37 M
|
| Income Before Tax |
-$206.58 M |
-$232.73 M |
-$333.11 M |
-$44.41 M |
$7.88 M |
| Income Before Tax Ratio
|
-0.2
|
-0.27
|
-0.5
|
-0.12
|
0.04
|
| Income Tax Expense |
-$20.32 M |
-$17.17 M |
-$25.91 M |
-$6.34 M |
$2.21 M |
| Net Income |
-$186.26 M |
-$215.56 M |
-$307.20 M |
-$38.07 M |
$5.67 M |
| Net Income Ratio |
-0.18 |
-0.25 |
-0.46 |
-0.1 |
0.03 |
| EPS |
-0.51 |
-0.61 |
-0.94 |
-0.1 |
0.0152 |
| EPS Diluted |
-0.51 |
-0.61 |
-0.94 |
-0.1 |
0.0152 |
| Weighted Average Shares
Out |
$367.46 M
|
$355.28 M
|
$327.52 M
|
$373.65 M
|
$373.65 M
|
| Weighted Average Shares
Out Diluted |
$367.46 M
|
$355.28 M
|
$327.52 M
|
$373.65 M
|
$373.65 M
|
| Link |
|
|
|
|
|
